EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NRas Nanoclusters Mediate Crosstalk Between BRAF/ERK and PI3K/AKT Signaling in Melanoma Cells

Oren Yakovian, Julia Sajman, Eilon Sherman iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Oren Yakovian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Racah Institute of Physics, The Hebrew University, Jerusalem 91904, Israel. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israeli Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanocyte signaling through the MAPK pathway is orchestrated by NRas and relayed downstream via multiple effectors, such as RAF, Ral, and PI3K. In spite of their significance, the molecular mechanisms of signaling relay by NRas, their dynamics, and their potential as therapeutic targets remain unclear. Using multi-color single molecule localization microscopy (PALM and dSTORM), we resolved the mutual nanoscale organization of NRas, PI3K, and BRAF at the plasma membrane of fixed and live melanoma cells. Surprisingly, NRas and its oncogenic mutation Q61R colocalized with PI3K in mutual nanoclusters, where BRAF was also frequently present. In live cells, NRas and PI3K co-clustering declined, yet persisted over minutes. Clinically relevant perturbations revealed unexpected crosstalk within these nanoclusters and consequently, between the MAPK and PI3K pathways. Specifically, overexpression of the Ras binding domain (RBD) and PI3K inhibition by wortmannin disrupted NRAS-PI3K interactions, and reduced both pAKT and pERK levels and cancer cell proliferation. MEK inhibition with trametinib resulted in similar, yet more pronounced effects. Thus, our findings provide novel insights into NRAS-mediated signaling through nanoscale clusters and underscore their potential as therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaProto-Oncogene Proteins B-rafPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktMembrane ProteinsGTP PhosphohydrolasesMAP Kinase Signaling SystemHumansCell Line, TumorSignal TransductionPyrimidinonesMutationCell ProliferationPyridones

Stichwörter der Autor:innen

AKTPI3KRasmelanomaprotein clusteringsingle molecule localization microscopysuper-resolution microscopy

Substanzen

Proto-Oncogene Proteins B-rafPhosphatidylinositol 3-KinasesNRAS protein, humanProto-Oncogene Proteins c-aktMembrane ProteinsGTP PhosphohydrolasesBRAF protein, humanPyrimidinonestrametinibPyridones

Autor:innen und Institutionen

  • Racah Institute of Physics, The Hebrew University, Jerusalem 91904, Israel.
  • Walder Department of Bioinformatics, Tal Campus for Women, Jerusalem College of Technology, Havaad Haleumi 21, Givat Mordechai, Jerusalem 91160, Israel.

ORCID-Profile: Eilon Sherman

Förderung

  • Israeli Science Foundation

Zitieren

APA

Yakovian, O., Sajman, J., & Sherman, E. (2025). NRas Nanoclusters Mediate Crosstalk Between BRAF/ERK and PI3K/AKT Signaling in Melanoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311647

Vancouver

Yakovian O, Sajman J, Sherman E. NRas Nanoclusters Mediate Crosstalk Between BRAF/ERK and PI3K/AKT Signaling in Melanoma Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311647

BibTeX
@article{Yakovian2025,
  author = {Yakovian, Oren and Sajman, Julia and Sherman, Eilon},
  title = {NRas Nanoclusters Mediate Crosstalk Between BRAF/ERK and PI3K/AKT Signaling in Melanoma Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311647}
}
Kostenlos starten →